<DOC>
	<DOCNO>NCT00204269</DOCNO>
	<brief_summary>The objective study examine efficacy tolerability three-year-Testosterone replacement therapy hypogonadal patient well patient 's compliance . The replacement therapy perform new Testosterone Gel examine previous trial Testosteron Gel Wolff .</brief_summary>
	<brief_title>Three-Year Trial New Testosterone Gel</brief_title>
	<detailed_description>The objective study examine efficacy tolerability three-year-Testosterone replacement therapy hypogonadal patient well patient 's compliance . The replacement therapy perform new Testosterone Gel examine previous trial Testosteron Gel Wolff ( TGW ) . A minimum 100 patient recruit evenly distribute two treatment arm . 1st arm : dermal ( non-scrotal ) application TGW . 2nd arm : scrotal application TGW .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>men hypergonadotropic hypogonadism hypogonadotropic hypogonadism lateonset hypogonadism combine initial Testosterone serum level &lt; 11 nmol/l know suspected carcinoma prostate clinically relevant abnormality clinical chemistry haematology severe medical condition opinion investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Hypogonadism</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Substitution</keyword>
</DOC>